Roche starts Covid-19 combo trial of anti-inflammatory drug, Gilead antiviral
Source: https://ift.tt/2Adtd6z
The Phase III study of Actemra with remdesivir is expected to start enrolling toward its target of 450 patients in June, with data being reported this summer.
Source: https://ift.tt/2Adtd6z
0 Comments